ABSTRACT The synthesis of ganglioside GM1 in intact rat liver Golgi-derived vesicles is stimulated by phosphatidylglycerol as much (about 20-fold) as by Triton X-100. The antibiotic tunicamycin inhibits strongly the synthesis, in the presence as well as in the absence of the phospholipid, but has no effect when Golgi membranes are solubilized with detergent. In Pronase-treated Golgi vesicles, which retain fill enzyme activity, both phospholipid dependence and tunicamycin inhibition of the synthesis disappear completely. When freshly prepared Golgi vesicles are incubated with 125 IAM UDP-[3H]Gal for 10 min at 30%C, the nucleotide sugar is found to be transported into the vesicles at an approximate rate of about 85 pmol/mg of protein per min, 92% of which remains firmly bound to the membrane. Tunicamycin inhibits this transport in a concentration-dependent manner. These results indicate the existence of carrier proteins in rat liver Golgi vesicles, which mediate the transport of the sugar nucleotide UDP-Gal, and that the carriers face the cytoplasmic side of the vesicles. The results also show that, although the mechanism of phosphatidylglycerolinduced stimulation of the synthetic activity remains unclear, tunicamycin inhibits ganglioside biosynthesis by blockdng the transport of the nucleotide sugar and not by inhibiting the transferase directly.
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One prerequisite step in ganglioside biosynthesis in the Golgi apparatus is the entrance of the sugar nucleotides from the outer side into the vesicles. This is because the sugar nucleotides are synthesized almost exclusively in the cytoplasm (1, 2) , whereas the glycosyltransferases that catalyze the transfer of sugar residues to glycolipid (and glycoprotein) acceptors are believed to face the Golgi lumen (3) (4) (5) (6) . Although the mechanism by which the activated sugars enter the lumen of the Golgi vesicles is unclear, recent studies of Sommers and Hirschberg (7) indicate the transport of CMP-NeuAc and GDP-Fuc to be mediated by carrier proteins.
In vitro studies reported thus far on ganglioside biosynthesis (8) (9) (10) (11) (12) (13) (14) have involved the use of detergents for solubilizing the membranes, so that the sugar nucleotides and other reaction components are directly available to the transferases. These studies, although providing valuable information on the functional properties of the enzymes, could not detect any carriermediated transport of the activated sugars. We developed a system in which full enzyme activity could be obtained, without disrupting the membrane vesicles; in Golgi vesicles isolated from rat liver, phosphatidylglycerol stimulates more strongly than octylglucoside (detergent) the synthesis of ganglioside GM2 (15) .
Tunicamycin, the antibiotic known to be an inhibitor of glycoprotein biosynthesis in microsomes (see ref. 16 for review), also inhibits the synthesis of ganglioside GM2 in Golgi membranes (15) and ganglioside biosynthesis in neuroblastoma cells (17) .
In this report, we present data on the stimulation by phosphatidylglycerol and inhibition by tunicamycin of GM1 synthesis in freshly prepared Golgi vesicles. We also present here experimental evidence that tunicamycin blocks the transport of UDP-Gal across Golgi membranes and not the transferase itself. (18) . Ovalbumin was obtained from Serva (Heidelberg). L-a-Phosphatidyl-D-glycerol, both naturally occurring (egg yolk; grade I) and synthetic (dipalmitoyl), and other phospholipids were obtained from Sigma and used after checking purity by TLC. Tunicamycin, CDP-choline, Pronase (protease, type XIV), and Triton X-100 were also from Sigma. Sodium cacodylate was from Fluka, Sephadex G-25 superfine was from Pharmacia, precoated silica gel 60 thin-layer plates were from Merck, and scintillation cocktail Rialuma was from Baker. Rats of the Wistar strain (300-350 g) were supplied by Hagemann (Extertal, FRG). All other reagents and solvents were of analytical grade quality.
Preparation of Golgi Vesicles. Golgi-rich membranes were isolated from rat liver, essentially by the method described by Sandberg et al. (19) . The final pellet of the Golgi membranes was resuspended in 0.3 M sucrose and stored at -26°C. When Abbreviations and enzymes: NeuAc, N-acetylneuraminic acid; DPH, 1,6-diphenyl-1,3,5-hexatriene; octylglucoside, 1-0-n-octyl-/3D-gluco- UDPacetylgalactos- Reactions were stopped with 1 ml of chloroform/methanol, 2:1 (vol/vol), and the samples were allowed to stand for 1-2 hr at room temperature. They were then applied to Sephadex G-25 superfine columns (bed vol, 1.5 ml), freshly developed with chloroform/methanol/water, 24:12:1.6 (vol/vol). Glycolipids were eluted with 3 vol of 1 ml of chloroform/methanol, 2:1 (vol/vol). The eluates, collected in scintillation vials, were evaporated to near dryness, mixed with 10 ml of Rialuma, and assayed for radioactivity in a Packard liquid scintillation counter. All assays were done at least in duplicate and mean values are presented; the standard deviation was usually within 5% of the mean values.
Product Identification. Reaction products were identified essentially as described (15) .
Protein Determination. Protein content of membrane preparations was determined according to Lowry et al. (20) with crystalline bovine serum albumin as the standard.
Transport Assay of UDP-Gal. Freshly prepared unpelleted Golgi vesicles were incubated along with UDP-[3H]Gal at 300C for 10 min, in presence of the indicated amounts of tunicamycin (see Fig. 3 ). The buffer, CDP-choline, and cation solutions were added, and the mixture was sonicated for 30 sec at 100 W. In contrast to the GM1-synthase experiments, in this case tunicamycin was added as follows: tunicamycin (1 mg) was suspended in 192 pul of water, thoroughly vortexed, and then ultrasonicated for 10 min (100 W). After centrifugation (5 min, 10,000 x g) aliquots of the clear supernatant were added to the incubation mixtures. (Tunicamycin concentration in the supernatant was determined by measuring absorption at 260 nm.) To check unspecific adsorption of the labeled sugar nucleotide to the membranes, one set of corresponding samples (in duplicate) was maintained at 0C for 10 min. After incubation, the reaction mixtures (both at 0 and 30'C) were diluted with 1 ml of ice-cold 0.3 M sucrose, containing the same concentration (125 /.M) of unlabeled UDPGal as during incubation. The samples were thoroughly mixed and centrifuged at 100,000 X g for 1 hr. The pellet surfaces were gently washed with 3 vol of 1.5 ml of ice-cold 0.3 M sucrose. The third wash contained background radioactivity (25-50 cpm/ml).
To separate soluble radioactivity associated with the pellet (7), the pellets were ultrasonicated with 0.5 ml of water in a water-cooled cup-horn sonicator for 5 min at maximal power (130 W). Perchloric acid [0.5 ml; 8% (wt/vol)] was added to the suspension and mixed thoroughly by mild vortexing. After keeping the samples on ice for 30 min, the membranes were pelleted by centrifugation at 20,000 X g for 30 min at 40C. Aliquots (0.5 ml) of the supernatant were removed for assaying soluble radioactivity. The pellet surfaces were then washed with 4% perchloric acid. To determine water/perchloric acid-insoluble radioactivity in the pellet, the pellets finally obtained as above were. dissolved in 1.5 ml of 2% NaDodSO4. Ultrasonication and heating for 30 min at 560C aided in complete solubilization of the membranes. The solutions were transferred into scintillation vials and the radioactivity was counted with 12 ml of Rialuma. Calculation of the rate of transport was done after subtraction of the values obtained at 00C from the corresponding values at 30'C.
RESULTS
Stimulation of GM1 Synthesis by Phosphatidylglycerol. A typical picture of the concentration-dependent stimulation of GM1 synthesis in rat liver Golgi vesicles by phosphatidylglycerol and by Triton X-100 is depicted in Fig. 1 . Synthetic phosphatidylglycerol (dipalmitoyl) was as active as the natural one. Phosphatidylethanolamine (at optimal concentration, 0.08%) was about 90% as active as phosphatidylglycerol. On the other hand, phosphatidylcholine (0.02%) was only 30% as active. The effect /vol) , or in n-butanol/acetic acid (glacial)/water 2:1:1 (vol/vol). In the case of column elution, the major radioactive product (>95%) comigrated with authentic ganglioside GM1 in both solvent systems, whether the enzyme reaction was in the presence of detergent (Triton X-100) or in the presence of phosphatidylglycerol. When products were extracted from washed membranes (reaction carried out in the presence of phospholipid), two radioactive bands of almost equal peak height appeared: one comigrated with GM1, whereas the other, presumably representing glycosylated proteins, remained at the origin. Therefore, the radioactivity measured in routine enzyme activity determinations (in column eluates) was almost exclusively due to ganglioside GM1. Moreover, each assay was corrected for the blank value (without lipid acceptor).
Inhibition of GM1 Synthesis by Tunicamycin. Results on GM1 synthesis (Fig. 2) show that tunicamycin at a concentration of 2.5 Ag/50 ,ug of Golgi protein causes about 85% inhibition of the synthesis, when the assays are carried out in presence of phosphatidylglycerol. However, the antibiotic has no effect on the synthetic activity when the membranes are solubilized by Triton X-100 (Fig. 2) . In the absence of phospholipid or detergent, the enzyme activity was low (5-10% of that in the presence), but tunicamycin inhibition (up to 70%) was observed in this case also (not shown).
The above results [as well as those of our study on GM2-synthase (15) posed, the latter being susceptible to Pronase treatment (7). We observed ( Table 1 ) that when freshly prepared Golgi vesicles are pretreated with Pronase (50 ,ug of Golgi protein with 1 Ag of Pronase), the resulting membranes lose their dependence on Triton X-100 or phosphatidylglycerol for optimal enzyme activity and that tunicamycin no longer inhibits the synthetic activity, even in the presence of the phospholipid. On the other hand, the control membranes (treated exactly the same way, but without Pronase), show both of these effects, although these are now relatively small (only 3.4-to 3.5-fold stimulation by Triton X-100 or phospholipid and up to 72% inhibition by 5 ,ug of tunicamycin) as compared to those found with Golgi vesicles used directly (see Figs. 1 and 2 ). The data of Table 1 also show that the Pronase-treated membranes retain full enzyme activity: the >2-fold enhancement of specific activity in the treated membranes is presumably due to the fact that Pronase treatment resulted in about 63% loss of vesicle protein, compared to 16% loss in controls, and that equal amounts (50 ,g) of membrane protein from each group were used for subsequent enzyme assays.
The above results suggest the existence of carriers for UDPGal across rat liver Golgi vesicles, which were partly or fully cleaved by Pronase, so that the resulting membranes no longer show any susceptibility towards tunicamycin. To obtain experimental evidence that tunicamycin inhibits the transport of UDP-Gal across Golgi membranes, Golgi vesicles were incubated with UDP-[3H]Gal (125 ,uM) for 10 min at 30°C in the presence or absence of tunicamycin. After incubation the membranes were pelleted, washed, and analyzed. The results on the rate of transport, after correction for unspecific adsorption (control incubations carried out at 0WC), are presented in Fig.  3 . More than 90% of the pellet radioactivity was found to be membrane-bound, indicating that most of the UDP-[3H]Gal that was transported into the vesicles was utilized by the glycoprotein galactosyltransferases. Therefore, the data shown in Fig. 3 represent an indirect measure of the transport rate. Based on these calculations, an approximate transport rate of about 85 pmol/mg of protein per min was observed for UDP-Gal at 30°C. Controls were run with Golgi vesicles disintegrated by ultrasonication for 45 sec in a water-cooled cup-horn sonicator at Biochemistry: Yusuf et al. maximal power. After this pretreatment, no inhibition was found of [3H]Gal incorporation into membrane-bound radioactivity, indicating that tunicamycin did not inhibit glycoprotein galactosyltransferases.
On the other hand, in freshly prepared Golgi vesicles tunicamycin inhibited the rate of transport in a concentration-dependent manner, the inhibition reaching about 71% at the antibiotic concentration of 0.28 jug/50 ,ug of Golgi protein. The radioactivity extractable with water represented only 7-8% of the total pellet radioactivity. Tunicamycin also decreased this radioactivity by up to about 20% (Fig. 3) . Incubation of the vesicles in the presence of phosphatidylglycerol (10 ,tg/50 jig of protein) did not alter either water-soluble or -insoluble radioactivity associated with. the pellet, whereas tunicamycin (0.14 pug/50 Ag of protein) in this case also decreased (by about 25%) the membrane-bound radioactivity (Fig. 3) .
The integrity of the Golgi preparation employed was also assessed by determining UDP-Gal:ovalbumin galactosyltransferase (Table 2) . Freshly prepared Golgi vesicles in the absence of detergents showed no appreciable galactosylation of ovalbumin. Addition of phosphatidylglycerol at the ratio optimal for ganglioside GM1-synthase activity (6 ,ug 
DISCUSSION
Golgi membranes, prepared by the method of Sandberg et al. (19) , were found to be highly enriched (50-to 60-fold), relative to rough microsomes or total homogenate, in GD3-, GM2-, and GM1-synthase activities. Determination of the specific activities of glucose-6-phosphatase (believed to be a marker enzyme for endoplasmic reticulum), acid phosphatase (lysosomes), and S'-nucleotidase (AMPase) (plasma membrane) indicated a maximum of 5% contamination of Golgi fraction with plasma membrane and <1% contamination with either microsomal or lysosomal membranes.
It was very surprising to find that tunicamycin, which is known to inhibit glycoprotein biosynthesis, strongly inhibited GM1 synthesis in unstimulated Golgi preparations (not shown) as well as in the presence of phosphatidylglycerol but had no effect when the reaction was stimulated by Triton X-100 (Fig. 2) . It was also observed that the degree of tunicamycin inhibition is a strict function of the intactness of Golgi vesicles: strongest inhibition is obtained with freshly prepared unpelleted vesicles, and the inhibition decreases after freezing and thawing of the vesicles and completely disappears when the vesicles are disrupted by ultrasonication. Similar results were also obtained with the GM2-synthase system (15) .
Pretreatment of intact Golgi vesicles with Pronase also abolishes tunicamycin inhibition (as well as phospholipid dependence) of the GM1 synthetic activity (Table 1) . These results as well as those described above clearly indicate that phospholipid does not stimulate and tunicamycin does not inhibit the glycosyltransferases; rather, the two opposing effects might relate to carrier-mediated transport of the nucleotide sugar across Golgi membranes. Existence of carriers for UDP-Gal across rat mammary gland Golgi membranes has been proposed (21, 22) . Our results with Pronase treatment also indicate that the carriers for UDP-Gal, like those for CMP-NeuAc and GDP-Fuc (7), face the cytoplasmic side of the vesicles. We assume that the protease digests the proteins protruding from the cytoplasmic side of the membranes, including some components of specific channel systems, but cannot attack the pore-or channel-forming proteins within the membrane. Such a treatment would create numerous pores wide enough for small molecules such as UDPGal to pass freely but too narrow for the protease to enter the lumen, as indicated by the full maintenance of GM1-synthase activity under these conditions. This assumption would also resolve the apparent contradiction that Pronase treatment of intact Golgi membranes reduces the transport of sugar nucleotides (4, 7) but stimulates ganglioside biosynthesis: when the sugar nucleotide can diffuse freely into the vesicles, this process is not arrested by chilling to 0°C. Therefore, the substances accumulated in the vesicle will be lost during workup of the samples and no net transport will be observed.
The interpretation of the results depends critically on the vesicular integrity of the Golgi vesicles employed for the experiments. Although it is hard to prove that the vesicles retain Proc. Natl. Acad. Sci. USA 80 (1983) 7079 their "right-side-out" orientation, we have several lines of evidence that this is in fact the case. Ganglioside GD1a-and GD3-synthases showed 12 and 14 times higher activities in the presence of Triton CF-54 than in its absence (not shown). Stimulation of GM1 synthesis by Triton X-100 was even greater, 21-fold (Fig. 1) . Both in this study and in that on GM2-synthase (15), the basal enzyme activity (in the absence of stimulatory agents) increased, whereas the activity in presence of the additives remained almost unaltered as the vesicles were pelleted, frozen, and thawed several times or disrupted by ultrasonication. Ultrasonically disrupted (four times, 30 sec each) Golgi vesicles lost about 50% of their transferase activity upon exposure to Pronase (50 ug of Golgi protein per 1 ,ug of Pronase) for 30 min at 300C (not shown), whereas almost no loss was found under identical conditions with intact vesicles (Table  1) . Another strong indication for the integrity of the freshly prepared Golgi vesicles used is their inability to glycosylate a macromolecular substrate such as ovalbumin ( Table 2 ). Addition of phosphatidylglycerol at the phospholipid-to-protein ratio optimal for stimulation of GM1 synthesis had no significant influence, indicating that it did not disturb vesicle integrity.
Solubilization of the membranes with Triton X-100 or disintegration by ultrasonication led to full activity towards the ovalbumin, which was not inhibited by tunicamycin. This again indicates that none of the glycosyltransferases studied was sensitive to tunicamycin. In contrast, all processes that require the transport of UDP-Gal across the Golgi membranes are inhibited by this antibiotic.
Based on the results presented in this paper, we therefore propose the following model: rat liver Golgi vesicles contain carriers that mediate the transport of UDP-Gal. The carriers, like those for CMP-NeuAc and GDP-Fuc (7), face the cytoplasmic side of the vesicles. Tunicamycin inhibits ganglioside biosynthesis in Golgi membranes by blocking the carriers for UDP-Gal and UDP-GalNac, not by inhibiting the transferase itself.
In support of this model, tunicamycin is found to inhibit strongly the in vio biosynthesis of gangliosides in neuronal cells, accompanied by a 4-fold accumulation in the cytoplasm of exogenously added nucleotide sugar (17) . Our contention that nucleotide sugar transport across Golgi membranes, the site for ganglioside biosynthesis, is blocked by tunicamycin is supported by the above findings.
